ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025
Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness.
Tomoka Mamori et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it